 |
| Lonza Viral Therapy Facility, Pearland, TX |
HOUSTON, TX –– HFF announces the sale and acquisition
financing of the Lonza Viral Therapy Facility, a, 276,770-square-foot
biotechnology facility in Pearland, Texas.
 |
| Jeff Hollinden |
The HFF team represented the seller, Pinchal & Co, and
procured the buyer, Zeller Realty Group (ZRG). Additionally, HFF worked
on behalf of ZRG to secure the fixed-rate acquisition loan through Bank of
Texas.
Completed in the fourth quarter 2017, the Lonza Viral Therapy
Facility is fully-leased on a long-term, triple net basis to Lonza America,
Inc., a wholly owned subsidiary of Lonza Group AG, a leading Swiss
biotechnology and pharmaceutical company.
The property is touted as the world’s largest
cell and gene therapy facility housing office space, a process development
unit, quality control laboratories, a fully segregated fill/finish suite and
independent modular cleanrooms designed to manufacture cell therapy
products.
The facility is situated on 11.01 acres at 14905
Kirby Drive in Pearland’s rapidly growing Lower Kirby Urban District. The
Lower Kirby Urban District is a 1,200-acre site that seeks to become a primary
life science destination building upon its location at the intersection of
Beltway 8 and State Highway 288, just eight miles south of the Texas Medical
Center, the largest medical district in the world.
 |
| Cameron Cureton |
HFF’s investment advisory and debt placement teams included senior
managing director Jeff Hollinden and senior director Cameron Cureton.
Holliday GP Corp. (“HFF”) is a Texas licensed real estate broker.
For more information, please
contact:
KRISTEN MURPHY
HFF
Director, Public Relations
(617) 338-0990
www. zellerrealty.com.
